Mark E. Laughlin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mark E. Laughlin has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Megin Nichols
Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
2 shared publicationsAimee L. Geissler
Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
1 shared publicationAlexandra Mercante
1 shared publicationAmber J. Singh
Ohio Department of Health, Columbus
1 shared publicationAnna Blackstock
1 shared publicationCharlotte G. Lane
Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
1 shared publication
Latest Publications
- Open Access
- 15 September 2021
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 4 (9) , e2125203
Ongoing Outbreak of Extensively Drug-ResistantCampylobacter jejuniInfections Associated With US Pet Store Puppies, 2016-2020
In the US, Campylobacter is the most common bacterial cause of diarrhea, with an estimated 1.5 million illnesses and an estimated 450 000 antibiotic-resistant infections each year.1,2 The proportion of resistant Campylobacter infections has doubled during the last 20 years.3 Approximately 30% have decreased susceptibility to fluoroquinolones (eg, ciprofloxacin) or macrolides (eg, azithromycin), agents used to treat severe infections.1 Resistant bacterial infections can require longer hospital stays, more medical visits, and more costly treatments with more toxic effects than susceptible infections.1
- 15 September 2021
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 4 (9) , e2125203
Open AccessOngoing Outbreak of Extensively Drug-ResistantCampylobacter jejuniInfections Associated With US Pet Store Puppies, 2016-2020
In the US, Campylobacter is the most common bacterial cause of diarrhea, with an estimated 1.5 million illnesses and an estimated 450 000 antibiotic-resistant infections each year.1,2 The proportion of resistant Campylobacter infections has doubled during the last 20 years.3 Approximately 30% have decreased susceptibility to fluoroquinolones (eg, ciprofloxacin) or macrolides (eg, azithromycin), agents used to treat severe infections.1 Resistant bacterial infections can require longer hospital stays, more medical visits, and more costly treatments with more toxic effects than susceptible infections.1
- 30 December 2016
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 65 (5051) , 1453-1454
Notes from the Field: Outbreak of Escherichia coli O157 Infections Associated with Goat Dairy Farm Visits — Connecticut, 2016
Fifty patients are identified in E. coli outbreak in Connecticut.
- 30 December 2016
- Published by Centers for Disease Control MMWR Office in MMWR. Morbidity and Mortality Weekly Report
- Vol. 65 (5051) , 1453-1454
Notes from the Field: Outbreak of Escherichia coli O157 Infections Associated with Goat Dairy Farm Visits — Connecticut, 2016
Fifty patients are identified in E. coli outbreak in Connecticut.